DEERE & CO - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERE & CO ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$283,000
+6.0%
27,567
+35.0%
0.02%
+7.1%
Q2 2016$267,000
-6.0%
20,413
-21.0%
0.01%
-6.7%
Q1 2016$284,000
+123.6%
25,836
+99.0%
0.02%
+114.3%
Q2 2015$127,000
+10.4%
12,9810.0%0.01%
+16.7%
Q1 2015$115,000
+0.9%
12,9810.0%0.01%0.0%
Q4 2014$114,000
-91.2%
12,981
-93.1%
0.01%
-91.7%
Q3 2014$1,291,000
+82.9%
187,418
+20.7%
0.07%
+80.0%
Q1 2014$706,000
+15.5%
155,252
+28.1%
0.04%
+29.0%
Q4 2013$611,000
+12.7%
121,242
+13.4%
0.03%0.0%
Q3 2013$542,000
+179.4%
106,882
+173.8%
0.03%
+158.3%
Q2 2013$194,00039,0350.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders